+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BVL BVL

Blueblood Ventures Share Price

₹11.07 +0 (0%)

29 May, 2023 11:34 AM (IST)

Blueblood Ventures live price: ₹11.07. It opened at ₹11 vs previous close ₹11; intraday high/low: ₹11/₹11. The 50 DMA stands at ₹13.30.

Blueblood Ventures Performance

  • Today's Low
  • ₹11
  • Today's High
  • ₹11
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹11
  • Previous Close₹11
  • Volume15,000
  • 50 DMA₹13.30
  • 100 DMA₹24.90
  • 200 DMA-

Blueblood Ventures Chart

Investment Returns

Smart Investing Starts Here Start SIP with Blueblood Ventures for Steady Growth!

Invest Now

Blueblood Ventures Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 101.9
  • PEG Ratio
  • -
  • Market Cap Cr
  • 3
  • P/B Ratio
  • 1.1
  • Average True Range
  • 0.9
  • EPS
  • 0.1
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.2
  • RSI
  • 55.65
  • MFI
  • 84.69

Latest Stock News Updates

Blueblood Ventures Ltd - 539637 - Pursuant To Regulations 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, We Wish To Inform You That The Board Of Directors Of The Company, At Its Meeting Held On Friday, 13Th November, 2026, Which Commenced At 10:00P.M. And Concluded At 11:30 P.M., Inter Alia, Considered And Transacted The Following Matters: 1. Approval Of Financial Results 2. Related Party Transactions 3. Loan Agreement 4. Assignment Of Debt

Outcome of Board Meeting

Blueblood Ventures Ltd - 539637 - Announcement under Regulation 30 (LODR)-Meeting Updates

The board has approved standalone half yearly results for the half year ended 30 sep,2026

Blueblood Ventures Ltd - 539637 - Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For The Board Has Decided To Approve Standalone Quarterly And Half Yearly Results Ended 30Th September,2026 Unaudited Financial Results For The Financial Year 2026-2027 Along With Auditors Report Thereon

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015. The Standalone Quarterly and Half Yearly Results ended 30th September,2026 unaudited Financial results for the Financial Year 2026-2027 along with auditor report thereon had been approved by the Board of Directors of the Company in its meeting held on 13th day of November,2026 and the said meeting commenced at 10:00 P.M. and Concluded at 11:30 P.M

Blueblood Ventures Financials

Blueblood Ventures Technicals

EMA & SMA

Current Price
₹11.07
0 (0%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 10
  • 20 Day
  • ₹9.60
  • 50 Day
  • ₹13.30
  • 100 Day
  • ₹24.90
  • 200 Day
  • -

Resistance and Support

11.09 Pivot Speed
  • R3 11.10
  • R2 11.10
  • R1 11.10
  • S1 11.10
  • S2 11.10
  • S3 11.10

Blueblood Ventures Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-13 Half Yearly Results
2026-10-09 Others
2026-05-27 Audited Results
2025-11-14 Half Yearly Results
2025-05-29 Audited Results

Blueblood Ventures Shareholding Pattern

53.12%
46.89%
0%

About Blueblood Ventures

Blueblood Ventures is engaged in the business of equity investment and trading in equity, derivatives, commodities, futures, and options, as well as other financialproducts. View More
  • NSE Symbol
  • BVL
  • BSE Symbol
  • 539637
  • Executive Director,Managing Director,Chief Financial Officer
  • Suresh Bohra
  • ISIN
  • INE562S01013

Similar Stocks to Blueblood Ventures

Blueblood Ventures FAQs

Blueblood Ventures share price is ₹11 As on 14 November, 2026 | 12:02

The Market Cap of Blueblood Ventures is ₹3.3 Cr As on 14 November, 2026 | 12:02

The P/E ratio of Blueblood Ventures is 101.9 As on 14 November, 2026 | 12:02

The PB ratio of Blueblood Ventures is 1.1 As on 14 November, 2026 | 12:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23